Home
NICE Guidance
Conditions and diseases
Mental health and behavioural conditions
Self-harm
Self-harm in over 8s: long-term management
Clinical guideline [CG133]
Published date:
November 2011
Uptake of this guidance
Guidance
Tools and resources
Information for the public
Evidence
History
Filter
Type
Cost Saving Guidance
Do not do
Key Therapeutic Topic
Public Health ROI tool
QP Case Study
Cochrane Topic
Published
2017
2016
2015
2014
2013
2012
Impact Level
Very Low
Low
High
Very High
Unclassified
Exclude
Varies locally
Do not use risk assessment tools and scales to predict future suicide or repetition of self-harm.
Do not do
November 2011
Unclassified
Do not use risk assessment tools and scales to determine who should and should not be offered treatment or who should be discharged.
Do not do
November 2011
Unclassified
When prescribing drugs for associated mental health conditions to people who self-harm, take into account the toxicity of the prescribed drugs in overdose. For example, when considering antidepressants, selective serotonin reuptake inhibitors (SSRIs) may be preferred because they are less toxic than other classes of antidepressants. In particular, do not use tricyclic antidepressants, such as dosulepin, because they are more toxic.
Do not do
November 2011
Unclassified
Show
10
25
50
All